Bone Graft and Substitutes Market - Trends,
Analysis and Forecast to 2025
A bone graft repairs and rebuilds diseased bone and transplants bone tissues of the hips, knees, spine,
and various other bones in the body. Moreover, it repairs bone loss caused by fractures and cancers.
The body accepts the newly implanted graft and provides a framework for growth of new living bone.
Bone grafts can be obtained either from the patient’s own body, a donor or can be entirely man-made
from natural or synthetic materials. Autografts and allograft are the most common types of bone grafts.
In Allograft, bone is obtained from a deceased donor or a cadaver that is sterilized and stored in the
tissue or bone banks. In autografts, bone is obtained from the patient’s own body parts such as ribs,
pelvis, wrist, and hips. Furthermore, bone graft substitutes made up of materials such as ceramics and
polymers are gaining preference. This is owing to osteoconductive and osteogenerative properties and
easy availability of these grafts.
Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-
sample/1050
Rise in trauma cases are responsible for accelerating growth of the global bone grafts and substitutes
market:
Bone grafting is majorly performed in cases of sinus lift, ridge augmentation, fracture repair, nerve
repositioning, and dental implantation. Bone damage is majorly attributed to rising incidence of trauma
and accident cases across the globe. According to the Centers for Disease Control and Prevention (CDC),
around 2.5 million people were hospitalized in the U.S. in 2014, due to accident injuries, indicating
high risk of bone damage. This in turn, increases the demand for bone grafts and substitutes. The
potential ability of bone grafting to repair the damage using natural mechanism can thus, be helpful and
incorporated for bone healing procedures. Moreover, the National Trauma Institute in 2014, revealed
that economic burden due to trauma cases increased to US$ 671 billion, including healthcare costs and
lost productivity costs. Among geographical regions, North America contributes the maximum share in
the bone grafts and substitutes market, owing to the increasing research and development activities in
the field of bone grafting, which results in development of innovative bone grafts in the region. For
instance, Artoss, Inc., a U.S.- based company introduced a complete line of bone grafts in 2017, which
incorporates use of nanotechnology in the production of these grafts. Various other factors such as
presence of key operating players and collaborative partnerships among the players are responsible for
positioning North America as the largest market for bone grafts and substitutes. On the other hand, Asia